| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-08 20:51:17 UTC |
|---|
| Updated at | 2022-09-08 20:51:17 UTC |
|---|
| NP-MRD ID | NP0273720 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (1s,3s,4s,5s,7r,8r)-7-ethyl-4-hydroxy-3-[(1e,3e,5e)-6-(4-methoxy-3-methyl-6-oxopyran-2-yl)hexa-1,3,5-trien-1-yl]-1,5-dimethyl-2,6-dioxabicyclo[3.2.1]octan-8-yl acetate |
|---|
| Description | Aurovertin b belongs to the class of organic compounds known as c-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a C-glycosidic bond. (1s,3s,4s,5s,7r,8r)-7-ethyl-4-hydroxy-3-[(1e,3e,5e)-6-(4-methoxy-3-methyl-6-oxopyran-2-yl)hexa-1,3,5-trien-1-yl]-1,5-dimethyl-2,6-dioxabicyclo[3.2.1]octan-8-yl acetate is found in Albatrellus confluens and Calcarisporium arbuscula. (1s,3s,4s,5s,7r,8r)-7-ethyl-4-hydroxy-3-[(1e,3e,5e)-6-(4-methoxy-3-methyl-6-oxopyran-2-yl)hexa-1,3,5-trien-1-yl]-1,5-dimethyl-2,6-dioxabicyclo[3.2.1]octan-8-yl acetate was first documented in 2005 (PMID: 16156519). Based on a literature review a significant number of articles have been published on aurovertin b (PMID: 26013262) (PMID: 19035880) (PMID: 32539922) (PMID: 30144974) (PMID: 22452346) (PMID: 18707016). |
|---|
| Structure | CC[C@H]1O[C@]2(C)[C@@H](OC(C)=O)[C@@]1(C)O[C@@H](\C=C\C=C\C=C\C1=C(C)C(OC)=CC(=O)O1)[C@@H]2O InChI=1S/C25H32O8/c1-7-20-24(4)23(30-16(3)26)25(5,33-20)22(28)18(32-24)13-11-9-8-10-12-17-15(2)19(29-6)14-21(27)31-17/h8-14,18,20,22-23,28H,7H2,1-6H3/b9-8+,12-10+,13-11+/t18-,20+,22-,23-,24-,25-/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C25H32O8 |
|---|
| Average Mass | 460.5230 Da |
|---|
| Monoisotopic Mass | 460.20972 Da |
|---|
| IUPAC Name | Not Available |
|---|
| Traditional Name | Not Available |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@H]1O[C@]2(C)[C@@H](OC(C)=O)[C@@]1(C)O[C@@H](\C=C\C=C\C=C\C1=C(C)C(OC)=CC(=O)O1)[C@@H]2O |
|---|
| InChI Identifier | InChI=1S/C25H32O8/c1-7-20-24(4)23(30-16(3)26)25(5,33-20)22(28)18(32-24)13-11-9-8-10-12-17-15(2)19(29-6)14-21(27)31-17/h8-14,18,20,22-23,28H,7H2,1-6H3/b9-8+,12-10+,13-11+/t18-,20+,22-,23-,24-,25-/m0/s1 |
|---|
| InChI Key | QXCOFYWOWZJFEA-DWUHWWJMSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as c-glycosyl compounds. These are glycoside in which a sugar group is bonded through one carbon to another group via a C-glycosidic bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | C-glycosyl compounds |
|---|
| Alternative Parents | |
|---|
| Substituents | - C-glycosyl compound
- Pyranone
- Dioxepane
- Alkyl aryl ether
- 1,4-dioxepane
- Pyran
- Oxane
- Monosaccharide
- Heteroaromatic compound
- Vinylogous ester
- Tetrahydrofuran
- Secondary alcohol
- Lactone
- Carboxylic acid ester
- Oxacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Ether
- Dialkyl ether
- Carboxylic acid derivative
- Organic oxide
- Hydrocarbon derivative
- Carbonyl group
- Alcohol
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Wang F, Luo DQ, Liu JK: Aurovertin E, a new polyene pyrone from the basidiomycete Albatrellus confluens. J Antibiot (Tokyo). 2005 Jun;58(6):412-5. doi: 10.1038/ja.2005.53. [PubMed:16156519 ]
- Mao XM, Xu W, Li D, Yin WB, Chooi YH, Li YQ, Tang Y, Hu Y: Epigenetic genome mining of an endophytic fungus leads to the pleiotropic biosynthesis of natural products. Angew Chem Int Ed Engl. 2015 Jun 22;54(26):7592-6. doi: 10.1002/anie.201502452. Epub 2015 May 27. [PubMed:26013262 ]
- Grover GJ, Malm J: Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia. Cardiovasc Ther. 2008 Winter;26(4):287-96. doi: 10.1111/j.1755-5922.2008.00065.x. [PubMed:19035880 ]
- Wu R, Yang X, Zhou Q, Yu W, Li M, Wo J, Shan W, Zhao H, Chen Y, Zhan Z: Aurovertin B exerts potent antitumor activity against triple-negative breast cancer in vivo and in vitro via regulating ATP synthase activity and DUSP1 expression. Pharmazie. 2020 Jun 1;75(6):261-265. doi: 10.1691/ph.2020.0380. [PubMed:32539922 ]
- Zhu H, Wang F, Ju X, Kong L, An T, Zhao Z, Liu J, Li Y: Aurovertin B sensitizes colorectal cancer cells to NK cell recognition and lysis. Biochem Biophys Res Commun. 2018 Sep 18;503(4):3057-3063. doi: 10.1016/j.bbrc.2018.08.093. Epub 2018 Aug 23. [PubMed:30144974 ]
- Cumero S, Fogolari F, Domenis R, Zucchi R, Mavelli I, Contessi S: Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone. Br J Pharmacol. 2012 Aug;166(8):2331-47. doi: 10.1111/j.1476-5381.2012.01958.x. [PubMed:22452346 ]
- Grover GJ, Marone PA, Koetzner L, Seto-Young D: Energetic signalling in the control of mitochondrial F1F0 ATP synthase activity in health and disease. Int J Biochem Cell Biol. 2008;40(12):2698-701. doi: 10.1016/j.biocel.2008.06.013. Epub 2008 Jul 30. [PubMed:18707016 ]
- Huang TC, Chang HY, Hsu CH, Kuo WH, Chang KJ, Juan HF: Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B. J Proteome Res. 2008 Apr;7(4):1433-44. doi: 10.1021/pr700742h. Epub 2008 Feb 15. [PubMed:18275135 ]
- Belogrudov GI: Bovine factor B: cloning, expression, and characterization. Arch Biochem Biophys. 2006 Jul 1;451(1):68-78. doi: 10.1016/j.abb.2006.02.021. Epub 2006 Mar 13. [PubMed:16579955 ]
- Gledhill JR, Walker JE: Inhibition sites in F1-ATPase from bovine heart mitochondria. Biochem J. 2005 Mar 15;386(Pt 3):591-8. doi: 10.1042/BJ20041513. [PubMed:15537385 ]
- LOTUS database [Link]
|
|---|